Skip to main
TEM
TEM logo

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI Inc. has demonstrated robust financial performance with a 35.9% year-over-year revenue growth, largely attributed to a 30.6% increase in Genomics revenue and a 44.6% increase in Data & Other segments. The company reported a net revenue retention (NRR) rate of approximately 140% in 2024, indicating a strong demand for its data solutions, despite management's caution regarding its sustainability. Additionally, the total contract value for data and services has reached around $940 million, signifying an increase in the company's market presence and the perceived value of its offerings in the healthcare data landscape.

Bears say

Tempus AI Inc. faces a challenging outlook following preliminary Q4 results that fell slightly below expectations, prompting a revenue forecast for FY24 to be revised down to approximately $693 million, down from previous guidance of $700 million. Additionally, potential declines in reimbursement rates and the risk of losing market share in genomic testing could further hinder the company's growth and ability to effectively monetize its dataset. Although the company's shares are currently trading at a discount compared to peer groups, these fundamental issues create significant uncertainties regarding Tempus's financial stability and future performance.

TEM has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 2 analysts, TEM has a Buy consensus rating as of Jul 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $72.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $72.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.